Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Alexander

Showing results (1161-1170 of 1,212) with videos related to

Pageof 122
Sort By:
NEJM Evidence|February 6, 2024
Apixaban or Warfarin in Patients with an On-X Mechanical Aortic ValveTracy Y Wang, Lars G Svensson, Jun Wen, et al.
Circulation|December 28, 2018
Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 TrialsAlexander C Fanaroff, Robert Clare, Karen S Pieper, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|June 3, 2024
Association between overweight and obesity with coronary artery bypass graft failure: an individual patient data analysis of clinical trialsKevin R An, Sigrid Sandner, Björn Redfors, et al.
JACC. Advances|June 18, 2026
The Effect of Restrictive vs Liberal Blood Transfusion Strategy on Subsequent Myocardial Infarction TypeAndrew P DeFilippis, J Dawn Abbott, Brandon M Herbert, et al.
Circulation|August 29, 2024
Restrictive Versus Liberal Transfusion in Patients With Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the MINT TrialAndrew P DeFilippis, J Dawn Abbott, Brandon M Herbert, et al.
JAMA Cardiology|March 26, 2025
Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use: A Subgroup Analysis of the OCEANIC-AF Randomized Clinical TrialJohn H Alexander, Elizabeth J Lydon, Jonathan P Piccini, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 9, 2022
Intimal hyperplasia, saphenous vein graft disease, and clinical outcomes: Insights from the CTSN VEST randomized trialDaniel J Goldstein, Helena L Chang, Michael J Mack, et al.
European Heart Journal|September 2, 2024
Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trialC Michael Gibson, Danielle Duffy, Maria Cecilia Bahit, et al.
British Journal of Pharmacology|December 20, 2023
The Concise Guide to PHARMACOLOGY 2023/24: TransportersStephen P H Alexander, Doriano Fabbro, Eamonn Kelly, et al.
The New England Journal of Medicine|September 3, 2024
Asundexian versus Apixaban in Patients with Atrial FibrillationJonathan P Piccini, Manesh R Patel, Jan Steffel, et al.
Pageof 122

Showing results (1161-1170 of 1,212) with videos related to

Sort By:
Pageof 122
NEJM Evidence|February 6, 2024
Apixaban or Warfarin in Patients with an On-X Mechanical Aortic ValveTracy Y Wang, Lars G Svensson, Jun Wen, et al.
Circulation|December 28, 2018
Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 TrialsAlexander C Fanaroff, Robert Clare, Karen S Pieper, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|June 3, 2024
Association between overweight and obesity with coronary artery bypass graft failure: an individual patient data analysis of clinical trialsKevin R An, Sigrid Sandner, Björn Redfors, et al.
JACC. Advances|June 18, 2026
The Effect of Restrictive vs Liberal Blood Transfusion Strategy on Subsequent Myocardial Infarction TypeAndrew P DeFilippis, J Dawn Abbott, Brandon M Herbert, et al.
Circulation|August 29, 2024
Restrictive Versus Liberal Transfusion in Patients With Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the MINT TrialAndrew P DeFilippis, J Dawn Abbott, Brandon M Herbert, et al.
JAMA Cardiology|March 26, 2025
Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use: A Subgroup Analysis of the OCEANIC-AF Randomized Clinical TrialJohn H Alexander, Elizabeth J Lydon, Jonathan P Piccini, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 9, 2022
Intimal hyperplasia, saphenous vein graft disease, and clinical outcomes: Insights from the CTSN VEST randomized trialDaniel J Goldstein, Helena L Chang, Michael J Mack, et al.
European Heart Journal|September 2, 2024
Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trialC Michael Gibson, Danielle Duffy, Maria Cecilia Bahit, et al.
British Journal of Pharmacology|December 20, 2023
The Concise Guide to PHARMACOLOGY 2023/24: TransportersStephen P H Alexander, Doriano Fabbro, Eamonn Kelly, et al.
The New England Journal of Medicine|September 3, 2024
Asundexian versus Apixaban in Patients with Atrial FibrillationJonathan P Piccini, Manesh R Patel, Jan Steffel, et al.
Pageof 122